FDA Adverse Event Malfunction Summary report: N

BD VACUTAINER® SST¿ BLOOD COLLECTION TUBES

MDR report key: 9438500 · Received December 9, 2019

Report

Report Number
1024879-2019-02091
Event Type
Malfunction
Date Received
December 9, 2019
Date of Event
November 21, 2019
Report Date
February 3, 2020
Manufacturer
BECTON, DICKINSON & CO., (BD)
Product Code
JKA
UDI-DI
50382903679831
PMA / PMN Number
BK050036
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
WI, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

H.6. INVESTIGATION: BD ACKNOWLEDGES THE CUSTOMER'S EXPERIENCE REGARDING THE INDICATED FAILURE MODE FOR POOR BARRIER SEPARATION WITH THE INCIDENT LOT A REVIEW OF THE DEVICE HISTORY RECORD WAS COMPLETED FOR THE INCIDENT LOT AND, BASED ON THIS REVIEW, ALL PRODUCT SPECIFICATIONS AND REQUIREMENTS FOR LOT RELEASE WERE MET; THERE WERE NO RELATED QUALITY NON-CONFORMANCES DURING MANUFACTURING OF THE PRODUCT. POOR BARRIER SEPARATION CAN BE CAUSED BY MANY SOURCES, INCLUDING CERTAIN PATIENT PATHOLOGICAL CONDITIONS, IMPROPER SPECIMEN COLLECTION, SPECIMEN PROCESSING, AND SPECIMEN TRANSPORT. SPECIMEN COLLECTION FACTORS THAT CAN CONTRIBUTE TO POOR BARRIER SEPARATION RANGE FROM PROLONGED TOURNIQUET TIME AND IMPROPER VENIPUNCTURE TECHNIQUE TO TRANSFERRING A SAMPLE FROM A SYRINGE DRAW OR IV CATHETER. SPECIMEN PROCESSING FACTORS INCLUDE VIGOROUS MIXING OR SHAKING OF THE SPECIMEN, NOT ALLOWING THE SPECIMEN TO CLOT FOR THE RECOMMENDED AMOUNT OF TIME, PROLONGED CONTACT OF SERUM OR PLASMA WITH CELLS, AND EXPOSURE TO EXCESSIVE HEAT OR COLD. FINALLY, MECHANICAL TRAUMA AND OTHER ADVERSE CONDITIONS DURING TRANSPORT OF TUBES CAN RESULT IN POOR BARRIER SEPARATION . H3 OTHER TEXT : SEE H.10.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE TUBE HAD AN INCOMPLETE GEL MIGRATION WITH A BD VACUTAINER® SST¿ BLOOD COLLECTION TUBES. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: CUSTOMER COMPLAINS OF INCOMPLETE GEL MIGRATION DESPITE PROPER PRE-ANALYTICAL HANDLING. ADDITIONAL INFORMATION RECEIVED: ARE PATIENT IDENTIFIERS KNOWN? IF SO, PLEASE PROVIDE (GENDER, AGE, DOB, WEIGHT, ETC.) NO. WAS FIBRIN PRESENT IN THE SERUM? NO. WERE THE RECOMMENDED CENTRIFUGATION G-FORCE, TIME, AND TEMPERATURE OBSERVED? YES. WHAT IS THE CENTRIFUGATION RAMP-UP SPEED? 3500 RPM. WHEN WAS THE CALIBRATION OF THE CENTRIFUGE LAST CHECKED? WHAT TYPE OF CENTRIFUGE WAS USED- FIXED ANGLE OR SWING BUCKET? SWING. WERE THE CENTRIFUGE SLEEVES BALANCED TO ASSURE PROPER PERFORMANCE? YES. IS THE CENTRIFUGE TEMPERATURE CONTROLLED? IF SO, TO WHAT TEMPERATURE IS IT SET? NO TEMP CONTROL. ARE THE TUBES BEING TRANSPORTED FROM ONE LOCATION TO ANOTHER, IF SO, BY WHAT MEANS (PNEUMATIC TUBE, ROBOT, HAND CARRIED, COURIER, GROUND VS. AIR)? YES VIA COURIER. ARE TUBES BEING STORED AT ROOM TEMPERATURE AND AWAY FROM DIRECT SUNLIGHT THROUGHOUT THEIR DISTRIBUTION AND USE? YES. DOES THE PATIENT HAVE ABNORMALLY HIGH PROTEIN LEVELS (PROTEIN DISORDER)? (B)(6) 2018. WHAT WAS STORAGE CONDITIONS? WHERE THEY STORED IN REFRIGERATOR PRIOR TO USE? NO.

Additional Manufacturer Narrative · 1

A DEVICE EVALUATION IS ANTICIPATED, BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE TUBE HAD AN INCOMPLETE GEL MIGRATION WITH A BD VACUTAINER® SST¿ BLOOD COLLECTION TUBES. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: CUSTOMER COMPLAINS OF INCOMPLETE GEL MIGRATION DESPITE PROPER PRE-ANALYTICAL HANDLING. ADDITIONAL INFORMATION RECEIVED: ARE PATIENT IDENTIFIERS KNOWN? IF SO, PLEASE PROVIDE (GENDER, AGE, DOB, WEIGHT, ETC.) NO. WAS FIBRIN PRESENT IN THE SERUM? NO. WERE THE RECOMMENDED CENTRIFUGATION G-FORCE, TIME, AND TEMPERATURE OBSERVED? YES. WHAT IS THE CENTRIFUGATION RAMP-UP SPEED? 3500 RPM. WHEN WAS THE CALIBRATION OF THE CENTRIFUGE LAST CHECKED? WHAT TYPE OF CENTRIFUGE WAS USED- FIXED ANGLE OR SWING BUCKET? SWING. WERE THE CENTRIFUGE SLEEVES BALANCED TO ASSURE PROPER PERFORMANCE? YES. IS THE CENTRIFUGE TEMPERATURE CONTROLLED? IF SO, TO WHAT TEMPERATURE IS IT SET? NO TEMP CONTROL. ARE THE TUBES BEING TRANSPORTED FROM ONE LOCATION TO ANOTHER, IF SO, BY WHAT MEANS (PNEUMATIC TUBE, ROBOT, HAND CARRIED, COURIER, GROUND VS. AIR)? YES VIA COURIER. ARE TUBES BEING STORED AT ROOM TEMPERATURE AND AWAY FROM DIRECT SUNLIGHT THROUGHOUT THEIR DISTRIBUTION AND USE? YES. DOES THE PATIENT HAVE ABNORMALLY HIGH PROTEIN LEVELS (PROTEIN DISORDER)? DECEMBER 2018. WHAT WAS STORAGE CONDITIONS? WHERE THEY STORED IN REFRIGERATOR PRIOR TO USE? NO.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1236945 BD VACUTAINER® SST¿ BLOOD COLLECTION TUBES BLOOD SPECIMEN COLLECTION DEVICE JKA BECTON, DICKINSON & CO., (BD) 367983 9164892 50382903679831

Patients

Seq Age Sex Outcome Treatment
1 Other